Literature DB >> 16573709

A to G transitions at 260, 386 and 437 in DAZL gene are not associated with spermatogenic failure in Indian population.

K Thangaraj1, S R Deepa, K Pavani, N J Gupta, P Reddy, A G Reddy, B N Chakravarty, L Singh.   

Abstract

The autosomal DAZL (Deleted-in-Azoospermic-Like) gene, mapped to the short arm of the human chromosome 3, is the precursor for the Y-chromosomal DAZ cluster, which encodes for putative RNA-binding proteins. Mutations in the DAZL have been reported to be associated with spermatogenic failure in Taiwanese population but not in Caucasians. As there was no study on Indian populations, we have analysed the entire coding sequences of exons 2 and 3 of DAZL in a total of 1010 men from Indian subcontinent, including 660 infertile men with 598 non-obstructive azoospermia, 62 severe oligozoospermia and 350 normozoospermic fertile control men, to investigate whether mutation(s) in the DAZL is associated with male infertility. Interestingly, none of our samples (1010) showed A386G (T54A) mutation, which was found to be associated with spermatogenic failure in Taiwanese population. In contrast, A260G (T12A) mutation was observed in both infertile and normozoospermic fertile control men, without any significant association with infertile groups (chi2= 0.342; p = 0.556). Similarly, we have found a novel A437G (I71V) mutation, which is also present in both infertile and normozoospermic fertile control men without any significant difference (chi2 = 0.476; p = 0.490). Our study clearly demonstrates the complete absence of the A386G (T54A) mutation in Indian subcontinent and the other two mutations --A260G (T12A) and A437G (I71V)--observed are polymorpic. Therefore, we conclude that these mutations in the DAZL gene are not associated with male infertility in Indian subcontinent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16573709     DOI: 10.1111/j.1365-2605.2006.00685.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  7 in total

1.  A386G transition in DAZL gene is not associated with spermatogenic failure in Tamil Nadu, South India.

Authors:  J Poongothai; T S Gopenath; S Manonayaki
Journal:  Indian J Hum Genet       Date:  2008-01

2.  A386G polymorphism of the DAZL gene is not associated with idiopathic male infertility in North India.

Authors:  Kiran Singh; Rajiva Raman
Journal:  J Hum Reprod Sci       Date:  2009-07

3.  Analysis of mitochondrial DNA variations in Indian patients with congenital cataract.

Authors:  Mascarenhas Roshan; Shama Prasada Kabekkodu; Pai H Vijaya; Kamath Manjunath; Jochen Graw; P M Gopinath; Kapeattu Satyamoorthy
Journal:  Mol Vis       Date:  2012-01-24       Impact factor: 2.367

Review 4.  Association of polymorphisms of A260G and A386G in DAZL gene with male infertility: a meta-analysis and systemic review.

Authors:  Ping Chen; Xiao Wang; Chang Xu; He Xiao; Wen-Hao Zhang; Xing-Huan Wang; Xin-Hua Zhang
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

Review 5.  Association between DAZL polymorphisms and susceptibility to male infertility: systematic review with meta-analysis and trial sequential analysis.

Authors:  Simin Zhang; Qiuqin Tang; Wei Wu; Beilei Yuan; Chuncheng Lu; Yankai Xia; Hongjuan Ding; Lingqing Hu; Daozhen Chen; Jiahao Sha; Xinru Wang
Journal:  Sci Rep       Date:  2014-04-10       Impact factor: 4.379

6.  High frequencies of Non Allelic Homologous Recombination (NAHR) events at the AZF loci and male infertility risk in Indian men.

Authors:  Deepa Selvi Rani; Singh Rajender; Kadupu Pavani; Gyaneshwer Chaubey; Avinash A Rasalkar; Nalini J Gupta; Mamta Deendayal; Baidyanath Chakravarty; Kumarasamy Thangaraj
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

7.  Identical mitochondrial somatic mutations unique to chronic periodontitis and coronary artery disease.

Authors:  Tokala Pallavi; Rampalli Viswa Chandra; Aileni Amarender Reddy; Bavigadda Harish Reddy; Anumala Naveen
Journal:  J Indian Soc Periodontol       Date:  2016 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.